Simulations Plus, Inc. (NASDAQ GSM: SLP) is the leading developer of modeling and simulation software for the pharmaceutical and biotechnology industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better project decisions… sooner.
Latest Quarterly Results
2nd Quarter Fiscal Year 2022 Results Press Release
2nd Quarter Fiscal Year 2022 Earnings Release Presentation
2nd Quarter Fiscal Year 2022 Webcast Info
Latest Investor Presentation
Upcoming Investor Presentations
Craig Hallum 19th Annual Institutional Investor Conference